Cargando…

Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?

At least one-third of all people with epilepsy have seizures that remain poorly controlled despite an increasing number of available anti-epileptic drugs (AEDs). Often, there is an initial good response to a newly introduced AED, which may last up to months, eventually followed by the return of seiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Woldman, Wessel, Cook, Mark J., Terry, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581121/
https://www.ncbi.nlm.nih.gov/pubmed/30981121
http://dx.doi.org/10.1016/j.yebeh.2019.03.003
_version_ 1783428139252187136
author Woldman, Wessel
Cook, Mark J.
Terry, John R.
author_facet Woldman, Wessel
Cook, Mark J.
Terry, John R.
author_sort Woldman, Wessel
collection PubMed
description At least one-third of all people with epilepsy have seizures that remain poorly controlled despite an increasing number of available anti-epileptic drugs (AEDs). Often, there is an initial good response to a newly introduced AED, which may last up to months, eventually followed by the return of seizures thought to be due to the development of tolerance. We introduce a framework within which the interplay between AED response and brain networks can be explored to understand the development of tolerance. We use a computer model for seizure generation in the context of dynamic networks, which allows us to generate an ‘in silico’ electroencephalogram (EEG). This allows us to study the effect of changes in excitability network structure and intrinsic model properties on the overall seizure likelihood. Within this framework, tolerance to AEDs – return of seizure-like activity – may occur in 3 different scenarios: 1) the efficacy of the drug diminishes while the brain network remains relatively constant; 2) the efficacy of the drug remains constant, but connections between brain regions change; 3) the efficacy of the drug remains constant, but the intrinsic excitability within brain regions varies dynamically. We argue that these latter scenarios may contribute to a deeper understanding of how drug resistance to AEDs may occur.
format Online
Article
Text
id pubmed-6581121
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-65811212019-06-24 Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy? Woldman, Wessel Cook, Mark J. Terry, John R. Epilepsy Behav Article At least one-third of all people with epilepsy have seizures that remain poorly controlled despite an increasing number of available anti-epileptic drugs (AEDs). Often, there is an initial good response to a newly introduced AED, which may last up to months, eventually followed by the return of seizures thought to be due to the development of tolerance. We introduce a framework within which the interplay between AED response and brain networks can be explored to understand the development of tolerance. We use a computer model for seizure generation in the context of dynamic networks, which allows us to generate an ‘in silico’ electroencephalogram (EEG). This allows us to study the effect of changes in excitability network structure and intrinsic model properties on the overall seizure likelihood. Within this framework, tolerance to AEDs – return of seizure-like activity – may occur in 3 different scenarios: 1) the efficacy of the drug diminishes while the brain network remains relatively constant; 2) the efficacy of the drug remains constant, but connections between brain regions change; 3) the efficacy of the drug remains constant, but the intrinsic excitability within brain regions varies dynamically. We argue that these latter scenarios may contribute to a deeper understanding of how drug resistance to AEDs may occur. Academic Press 2019-05 /pmc/articles/PMC6581121/ /pubmed/30981121 http://dx.doi.org/10.1016/j.yebeh.2019.03.003 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Woldman, Wessel
Cook, Mark J.
Terry, John R.
Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title_full Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title_fullStr Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title_full_unstemmed Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title_short Evolving dynamic networks: An underlying mechanism of drug resistance in epilepsy?
title_sort evolving dynamic networks: an underlying mechanism of drug resistance in epilepsy?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581121/
https://www.ncbi.nlm.nih.gov/pubmed/30981121
http://dx.doi.org/10.1016/j.yebeh.2019.03.003
work_keys_str_mv AT woldmanwessel evolvingdynamicnetworksanunderlyingmechanismofdrugresistanceinepilepsy
AT cookmarkj evolvingdynamicnetworksanunderlyingmechanismofdrugresistanceinepilepsy
AT terryjohnr evolvingdynamicnetworksanunderlyingmechanismofdrugresistanceinepilepsy